SPOSETTI, CATERINA
 Distribuzione geografica
Continente #
EU - Europa 273
NA - Nord America 71
AS - Asia 67
SA - Sud America 16
OC - Oceania 3
AF - Africa 1
Totale 431
Nazione #
DE - Germania 165
US - Stati Uniti d'America 68
IT - Italia 42
SG - Singapore 27
BR - Brasile 16
CN - Cina 15
FR - Francia 10
HK - Hong Kong 10
NL - Olanda 9
SE - Svezia 7
RU - Federazione Russa 6
CH - Svizzera 5
GB - Regno Unito 5
ID - Indonesia 4
AT - Austria 3
AU - Australia 3
DK - Danimarca 3
ES - Italia 3
FI - Finlandia 3
IN - India 3
BE - Belgio 2
CA - Canada 2
HR - Croazia 2
IE - Irlanda 2
JO - Giordania 2
KZ - Kazakistan 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
EG - Egitto 1
IQ - Iraq 1
JM - Giamaica 1
TR - Turchia 1
Totale 431
Città #
Frankfurt am Main 151
Rho 19
Singapore 15
Santa Clara 11
Council Bluffs 6
Hong Kong 5
Milan 5
Jakarta 4
Los Angeles 4
Shanghai 4
Winston-Salem 4
Desio 3
Leiden 3
Odense 3
Perth 3
Pisa 3
Zurich 3
Aachen 2
Airdrie 2
Amman 2
Baia Mare 2
Beneditinos 2
Bengaluru 2
Berlin 2
Bratislava 2
Brussels 2
Caxias 2
Chicago 2
De Bilt 2
Denver 2
Dublin 2
Fargo 2
Genoa 2
Governador Valadares 2
Hilton 2
La Jolla 2
Lappeenranta 2
Leipzig 2
Madrid 2
Munich 2
North Berwick 2
Nuremberg 2
Paris 2
Quimper 2
Schlieren 2
Setúbal 2
Strasbourg 2
Tassin-la-Demi-Lune 2
Teresina 2
Toulouse 2
Varallo Pombia 2
Vienna 2
Waldkirch 2
Zagreb 2
Astana 1
Balneário Camboriú 1
Beijing 1
Boston 1
Carlsbad 1
Cassina Rizzardi 1
Columbus 1
Cotia 1
Dubai 1
Eitensheim 1
Forest City 1
Griffith 1
Helsinki 1
Hyderabad 1
Itapevi 1
Maceió 1
Mosul 1
Naples 1
Novo Hamburgo 1
Osasco 1
Phoenix 1
Quanzhou 1
Rochester 1
Rome 1
Romford 1
Schmallenberg 1
Shenzhen 1
Silver Spring 1
Sorocaba 1
São Paulo 1
Turin 1
Valencia 1
Zagazig 1
Zyryanovsk 1
Totale 354
Nome #
Adding fasting-mimicking diet to first-line carboplatin-based chemotherapy is associated with better overall survival in advanced triple-negative breast cancer patients: A subanalysis of the NCT03340935 trial 126
Real-world progression-free survival 2 with CDK4/6 inhibitors plus endocrine therapy and subsequent line: Results from the multicenter SISTER study 117
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study 94
Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatments 60
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors 32
Breast cancers arising in subjects with germline BRCA1 or BRCA2 mutations: Different biological and clinical entities with potentially diverse therapeutic opportunities 16
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors 6
null 3
The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis 1
Abstract HER2-02: HER2-02 HER2-Low Status is Associated with Worse Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Patients Treated With First-Line Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Therapy 1
Survival Following CDK4/6 Inhibitor Therapy for Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer 1
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study 1
Totale 458
Categoria #
all - tutte 1.227
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.227


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20238 0 0 0 0 1 2 1 0 0 0 4 0
2023/2024117 2 0 2 5 7 5 16 14 6 17 17 26
2024/2025333 19 22 24 53 42 29 41 62 41 0 0 0
Totale 458